Overall survival vs disease-free survival and other surrogate endpoints - survival-analysis - Datamethods Discussion Forum
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
VisualAbstract: Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer | 2 Minute Medicine
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials - European Journal of Cancer
The Essentials of GI Malignancies: Maximizing the Therapeutic Potential
A) Disease-free survival, (B) progression-free survival and (C)... | Download Scientific Diagram
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma | Haematologica
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India
Disease Free Survival - an overview | ScienceDirect Topics
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Kaplan-Meier survival curves for disease-free survival and overall... | Download Scientific Diagram
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial - Annals of
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
View Image
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer | British Journal of Cancer
Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf
![PDF] Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/54299cb7a5bb25860c06f989601d90c07b81bf18/4-Figure2-1.png "PDF] Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer | Semantic Scholar")
PDF] Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer | Semantic Scholar
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
